ALS (also known as Lou Gehrig's Disease) is a progressive neuromuscular disease in which nerve cells die and leave voluntary muscles paralyzed.

Every day two or three Canadians die of the disease.

Learn More About ALS

Events CalendarHealthcare ProvidersClinical TrialsHelp End ALSALS and Youth

 

    

       
 

ALS News

MARKHAM, ON, May 9, 2013 /CNW/ - ALS Canada is amplifying its efforts to find a cure and offer the best support for Canadians with amyotrophic lateral sclerosis (ALS). Six new board members, with a breadth of experience in finance, education and research, will guide the organization in minimizing the hardships caused by ALS.

TORONTO, May 2, 2013 /CNW/ - Years of steadfast Canadian commitment to advancing high-risk, high-potential research pays new dividends in the fight against ALS, commonly known as Lou Gehrig's disease. Canadian scientists are major players on the international scene in terms of discoveries, productivity, collaborations in clinical trials and contributions to science. Based on peer-reviewed publications per capita, Canadian scientists are leaders in the G8.

Ontario Client Services is very pleased to announce the start of an exciting new program. Effective April 1st, clients and families in the Toronto area who require enhanced emotional support can access services of a Psychologist through their Regional Manager. This program was developed with the assistance of staff involved with the Psychology Support Program of ALS Society of British Columbia.

Ontario Client Services is eagerly seeking your input on how we are doing. Each month a random sample of clients who received equipment from the equipment loan pool the previous month will be sent a survey

ALS Canada - Ontario Client Services continues to be committed to providing services to the approximately 1,100 individuals and their families living with ALS in Ontario by expanding our service coverage.

In what he describes as, "a purely Canadian discovery", Dr. Michael Strong`s laboratory at Western University have discovered a new gene that causes ALS.  Last year, a project led by postdoctoral fellow Dr. Cristian Droppelmann described a protein called rho guanine nucleotide exchange factor (RGNEF) which was identified in clumps (called aggregates or inclusions) that appear inside of sick motor neurons and have long been associated with the disease pathology.